4,587 reports of this reaction
2.0% of all ANTI PRURITIC reports
#6 most reported adverse reaction
RASH is the #6 most commonly reported adverse reaction for ANTI PRURITIC, manufactured by A2A Integrated Pharmaceuticals, LLC. There are 4,587 FDA adverse event reports linking ANTI PRURITIC to RASH. This represents approximately 2.0% of all 229,196 adverse event reports for this drug.
Patients taking ANTI PRURITIC who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH is a less commonly reported adverse event for ANTI PRURITIC, but still significant enough to appear in the safety profile.
In addition to rash, the following adverse reactions have been reported for ANTI PRURITIC:
The following drugs have also been linked to rash in FDA adverse event reports:
RASH has been reported as an adverse event in 4,587 FDA reports for ANTI PRURITIC. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH accounts for approximately 2.0% of all adverse event reports for ANTI PRURITIC, making it a notable side effect.
If you experience rash while taking ANTI PRURITIC, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.